Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

3M: Intelligent Control Inhaler

Integrated device delivers accurate doses to patients, provides onscreen usage instructions and uses an app to provide feedback to patient and health care provider.

3M's Integrated device delivers accurate doses to patients, provides onscreen usage instructions and uses an app to provide feedback to patient and health care provider.
3M's Integrated device delivers accurate doses to patients, provides onscreen usage instructions and uses an app to provide feedback to patient and health care provider.

3M Drug Delivery Systems’ 3M™ Intelligent Control Inhaler is an intuitive, fully integrated device that delivers accurate doses to patients, while providing on-screen instructions for use and feedback to the patient and health care provider via an app.

The 3M Intelligent Control Inhaler provides a number of unique features that offer opportunities to improve outcomes by reducing patient variability and errors, and providing data on use to health care providers and payers:

• Controlled inspiration: a combination of breath actuation with innovative technology to control inspiratory flow rate significantly reduces errors in technique, and results in a much higher level of consistency of drug delivery between breaths and between patients.

• Integrated patient instructions: the inhaler’s patient-proof design gives patients confidence to use the inhaler correctly and helps eliminate critical errors in use, as well as minimizing the resources dedicated to training patients in correct inhalation technique.

• Fully integrated device: the dose is registered when the patient correctly inhales medication rather than on actuation of the device, delivering greater accuracy of information for the patient, and cost-savings for health care providers who can avoid unnecessary switches and treatment escalation.

• Capture of inspiration data: the inhaler utilizes a data management platform to record not only device usage, but also inspiration profiles to help monitor disease progression, further supporting informed treatment decisions.

The device will be developed in partnership with a pharmaceutical company, and is expected to be in wide use by the end of the decade.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO